ACADIA Pharmaceuticals: Q2 Earnings Insights

ACADIA Pharmaceuticals ACAD reported its Q2 earnings results on Monday, August 8, 2022 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

ACADIA Pharmaceuticals beat estimated earnings by 16.0%, reporting an EPS of $-0.21 versus an estimate of $-0.25.

Revenue was up $19.34 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.1 which was followed by a 5.33% drop in the share price the next day.

Here's a look at ACADIA Pharmaceuticals's past performance:

To track all earnings releases for ACADIA Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.